Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ·Healthcare·Biotechnology
$10.45
+1.75%
Mkt Cap $786.39M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (16 analysts)
$24.67
Range $18.00 – $28.00
Implied Upside
+136.1%
Consensus $24.67 vs current $10.45
NASDAQ·Healthcare·Biotechnology
$10.45
+1.75%
Mkt Cap $786.39M
Buy
2
Hold
0
Sell
0
Price Target (16 analysts)
$24.67
Range $18.00 – $28.00
+136.1%
Consensus $24.67 vs current $10.45